Models for vaccine assessment
View Patent ↗The present invention is directed to methods for constructing and using in vivo and in vitro models of aspects of human immunity and, in particular, construction of a human immune system model for the testing of, for example, vaccines, adjuvants, immunotherapy candidates, cosmetics, drugs, biologics and other chemicals. The present invention comprises both in vivo and in vitro models of aspects of human immunity that are useful for assessing the interaction of substances with the immune system, and thus can be used to accelerate and improve the accuracy and predictability of, for example, vaccine, drug, biologic, immunotherapy, cosmetic and chemical development. The invention is also useful for the generation of human monoclonal and polyclonal antibodies.
1. An in vitro method of enhancing antigen-induced responsiveness of B cells in a population comprising:
a) prepulsing a population of dendritic cells (DCs) with a selected antigen to obtain an antigen-prepulsed DC population;
b) culturing the antigen-prepulsed DC population of a) with a population of T cells to obtain a T/DC/Ag cell population;
c) prepulsing a population of B cells with the selected antigen followed by removal of the antigen to obtain an antigen-prepulsed B cell population (B-Ag); and
d) co-culturing the T/DC/Ag cell population of b) with the B-Ag cell population of c), after at least about 24 hours of culturing in b), to obtain a T/DC+B-Ag co-culture under conditions permitting a B cell response; wherein the number of B cells producing antibody in the T/DC+B-Ag co-culture is greater than the number of B cells producing antibody in a co-culture in which the T cells were co-cultured with an antigen-prepulsed DC population for less than 24 hours prior to addition of antigen-prepulsed B cells; thereby enhancing antigen-induced responsiveness of B cells in a population.
2. The method of claim 1 , wherein the culturing of b) is for about three days.
3. An in vitro method of enhancing antigen-induced responsiveness of B cells in a population comprising:
a) prepulsing a population of dendritic cells (DCs) with a selected antigen to obtain a first antigen-prepulsed DC population;
b) culturing the first antigen-prepulsed DC population of a) with a population of T cells to obtain a T/DC/Ag cell population;
c) prepulsing a second population of DCs with the selected antigen to obtain a second antigen-prepulsed DC population;
d) culturing the second antigen-prepulsed DC population of c) with a population of B cells to obtain a B cell-dendritic cell population (B-DC);
e) co-culturing the T/DC/Ag cell population of b) with the B-DC cell population of d) after at least about 24 hours of culturing in b), to obtain a T/DC+B-DC co-culture under conditions permitting a B cell response; wherein the number of B cells producing antibody in the T/DC+B-DC co-culture is greater than the number of B cells producing antibody in a co-culture in which the T cells were co-cultured with an antigen-prepulsed DC population for less than 24 hours prior to addition of B cell-dendritic cells; thereby enhancing antigen-induced responsiveness of B cells in a population.
4. The method of claim 3 , wherein the culturing of b) is for about three days.
5. The method of claim 1 , further comprising: e) separating antibody-producing B cells from the T/DC+B-Ag co-culture.
6. The method of claim 3 , further comprising: e) separating antibody-producing B cells from the T/DC+B-DC co-culture.